1-20 of 163
Marco Ladetto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TP53 , CD36 Mutations and CDKN2A Loss Predict Poor Outcome in Mantle Cell Lymphoma: Molecular Analysis of the FIL V-Rbac Phase 2 Trial

Riccardo Moia, Maria Elena Carazzolo, Chiara Cosentino, Mohammad Almasri, Donatella Talotta, Valentina Tabanelli, Giovanna Motta, Federica Melle, Maria Vittoria Sacchi, Andrea Evangelista, Luca Cividini, Maria Chiara Tisi, Merli Anna, Stefano Fiori, Alessandro Re, Claudia Castellino, Vittorio Ruggero Zilioli, Francesco Piazza, Paolo Corradini, Stefan Hohaus, Gerardo Musuraca, Francesca Gaia Rossi, Benedetta Puccini, Federica Cavallo, Filippo Ballerini, Roberta Sciarra, Alice Di Rocco, Annalisa Arcari, Carola Boccomini, Francesco Merli, Guido Gini, Monica Tani, Riccardo Bruna, Vincenzo Pavone, Marco Ladetto, Sara Galimberti, Riccardo Bomben, Valter Gattei, Ilaria Del Giudice, Simone Ferrero, Stefano Pileri, Monica Balzarotti, Gianluca Gaidano, Carlo Visco
Journal: Blood
Blood (2024) 144 (Supplement 1): 1577.
https://doi.org/10.1182/blood-2024-198076
Published: 2024
Journal Articles

Impact of Minimal Residual Disease Analysis in the Era of Rituximab Maintenance in Follicular Lymphoma: Data from “FOLL12” Phase III Trial of the Fondazione Italiana Linfomi

Simone Ferrero, Ilaria Del Giudice, Sara Galimberti, Valter Gattei, Luigi Marcheselli, Elisa Genuardi, Daniela Drandi, Mariapia Pironti, Irene Dogliotti, Aurora Maria Civita, Irene Della Starza, Giovanni Manfredi Assanto, Francesca Guerrini, Clara Bono, Riccardo Bomben, Carola Boccomini, Lucia Farina, Jacopo Olivieri, Luca Arcaini, Federica Cavallo, Filippo Ballerini, Gloria Margiotta Casaluci, Vittorio Ruggero Zilioli, Manuela Zanni, Gerardo Musuraca, Anna Merli, Benedetta Bianchi, Silvia Bolis, Vincenzo Pavone, Annalisa Chiarenza, Annalisa Arcari, Catello Califano, Samantha Pozzi, Massimo Massaia, Annarita Conconi, Tommasina Perrone, Donato Mannina, Alessandro Re, Maria Elena Nizzoli, Dimitri Dardanis, Stefano Luminari, Marco Ladetto
Journal: Blood
Blood (2024) 144 (Supplement 1): 339.
https://doi.org/10.1182/blood-2024-194832
Published: 2024
Journal Articles

Waveline-007: Dose Escalation and Confirmation, and Efficacy Expansion Trial of Zilovertamab Vedotin in Combination with Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab in Patients with Diffuse Large B Cell Lymphoma

Muhit Ozcan, Eva Gonzalez Barca, Tae Min Kim, Ewa Paszkiewicz-Kozik, Jan M. Zaucha, Stefan Hohaus, Marco Ladetto, Caterina Patti, Sebastian Giebel, Tadeusz Robak, Ömür Gökmen Sevindik, Yulia Volchek, Benedetta Puccini, Guillermo Rodríguez Garcia, Raul Cordoba, Okan Seyran, Siruo Wang, L. Puja Patel, Rushdia Yusuf, David Lavie
Journal: Blood
Blood (2024) 144 (Supplement 1): 578.
https://doi.org/10.1182/blood-2024-200271
Published: 2024
Journal Articles

A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection

Monia Marchetti, Paolo Corradini, Luca Arcaini, Stefania Bramanti, Alice Di Rocco, Marco Ladetto, Stefano Luminari, Luigi Rigacci, Pier Luigi Zinzani
Journal: Blood
Blood (2024) 144 (Supplement 1): 2269.
https://doi.org/10.1182/blood-2024-198647
Published: 2024
Journal Articles

Role of Autologous Stem Cell Transplantation in the Context of Ibrutinib-Containing First-Line Treatment in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network

Martin Dreyling, Jeanette K Doorduijn, Eva Gine, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trneny, Vibeke KJ Vergote, Daniela Donnarumma, Ofer Shpilberg, Maria Gomes da Silva, Sirpa Leppä, Linmiao Jiang, Christiane Pott, Wolfram Klapper, Christian Schmidt, Michael Unterhalt, Marco Ladetto, Eva Hoster
Journal: Blood
Blood (2024) 144 (Supplement 1): 240.
https://doi.org/10.1182/blood-2024-200735
Published: 2024
Journal Articles

Impact of Rituximab Maintenance Added to Ibrutinib-Containing Regimens with and without ASCT in Younger, Previously Untreated MCL Patients: An Analysis of the Triangle Data Embedded in the Multiply Project

Marco Ladetto, Katja Gutmair, Jeanette K Doorduijn, Eva Gine, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trneny, Vibeke KJ Vergote, Piero Maria Stefani, Netanel A. Horowitz, Maria Gomes da Silva, Sirpa Leppä, Linmiao Jiang, Christiane Pott, Wolfram Klapper, Christian Schmidt, Michael Unterhalt, Martin Dreyling, Eva Hoster
Journal: Blood
Blood (2024) 144 (Supplement 1): 237.
https://doi.org/10.1182/blood-2024-201441
Published: 2024
Journal Articles

PRIMAVERA: A Modular Phase I/II Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, in Participants with Relapsed/Refractory Hematologic Malignancies

Tae Min Kim, Katharine L. Lewis, Juan Pablo Alderuccio, Hun Ju Lee, Enrico Derenzini, Pier Luigi Zinzani, Marco Ladetto, Elizabeth H. Phillips, Hervé Ghesquieres, François Lemonnier, Franck Morschhauser, Ana Sureda Balari, Antonia Rodriguez Izquierdo, Peter Borchmann, Matthew Weinstock, Jakub Svoboda, Emma Dean, Jelena Urosevic, Stefanie Meyer, Robert Chen, Richard Olsson, Kaitlyn Beyfuss, Graham P. Collins
Journal: Blood
Blood (2024) 144 (Supplement 1): 1674.2.
https://doi.org/10.1182/blood-2024-203060
Published: 2024
Journal Articles

Mosunetuzumab and Zanubrutinib in Relapsed/Refractory Follicular Lymphoma Patients (MOZART): A Phase II, Chemo-Free Trial from Fondazione Italiana Linfomi (FIL)

Marco Ladetto, Rita Tavarozzi, Matthew Ku, Luca Arcaini, Carola Boccomini, Beatrice Casadei, Annalisa Chiarenza, Annarita Conconi, Ilaria Del Giudice, Michele Merli, Maria Elena Nizzoli, Stefano Luminari
Journal: Blood
Blood (2024) 144 (Supplement 1): 3042.1.
https://doi.org/10.1182/blood-2024-201305
Published: 2024
Journal Articles

Trial in Progress: A Phase II Trial to Investigate Venetoclax in Combination with Ibrutinib and Rituximab or Conventional Chemoimmunotherapy (Bendamustine and Rituximab) and Ibrutinib in Patients with Treatment-Naive Mantle Cell Lymphoma Not Eligible for High-Dose Therapy - MCL Elderly III

Stephanie Herold, Anke Ohler, Marie-Kristin Tilch, Christian Schmidt, Michael Unterhalt, Eva Hoster, Elisabeth Hoenig, Susanne Singer, Carlo Visco, Marco Ladetto, Alessandra Tucci, Christiane Pott, Georg Hess, Martin Dreyling
Journal: Blood
Blood (2024) 144 (Supplement 1): 3042.2.
https://doi.org/10.1182/blood-2024-204691
Published: 2024
Journal Articles

Progression-Free Survival but Not Overall Survival Is Superior in Relapsed/Refractory Large B-Cell Lymphomas Treated with Axicabtagene Ciloleucel Compared to Tisagenlecleucel: Results of the CART-SIE Real Life Italian Study

Annalisa Chiappella, Anna Dodero, Beatrice Casadei, Chiara De Philippis, Silva Ljevar, Eugenio Galli, Alice Di Rocco, Matteo Giovanni Carrabba, Maria Chiara Tisi, Maurizio Musso, Ilaria Cutini, Anna Maria Barbui, Mirko Farina, Massimo Martino, Anna Guidetti, Barbara Botto, Giovanni Grillo, Jacopo Olivieri, Martina Pennisi, Mauro Krampera, Marco Ladetto, Massimo Massaia, Luca Arcaini, Federica Cavallo, Rosalba Miceli, Maurizio Martelli, Patrizia Chiusolo, Stefania Bramanti, Pier Luigi Zinzani, Paolo Corradini
Journal: Blood
Blood (2023) 142 (Supplement 1): 2118.
https://doi.org/10.1182/blood-2023-189300
Published: 2023
Journal Articles

Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study

Selim Corbacioglu, Jarl Mooyaart, Emmanuelle Polge, William Boreland, Jessica Lemaitre, Christophe Peczynski, Anja van Biezen, Thomas Schroeder, Henrik Sengeloev, Daniele Avenoso, Peter Brossart, Eleni Gavriilaki, Maria Caterina Mico', Carmen Martínez, Manuel Jurado Chacón, Simona Sica, Stella Santarone, Stig Lenhoff, Marco Ladetto, Jose A. Pérez-Simón, Yves Beguin, Stefan Klein, Maria Jesús Pascual, Sibel Gunes, Catalin Bobirca, Olaf Penack, Zinaida Perić
Journal: Blood
Blood (2023) 142 (Supplement 1): 7016.
https://doi.org/10.1182/blood-2023-177866
Published: 2023
Journal Articles

Rituximab and Lenalidomide (R 2 ) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL)

Carola Boccomini, Barbara Botto, Andrea Evangelista, Vittorio Ruggero Zilioli, Antonella Anastasia, Federica Cavallo, Francesco Merli, Manuela Zanni, Monica Tani, Annalisa Chiarenza, Anna Marina Liberati, Annarita Conconi, Paolo Corradini, Alessia Bari, Giorgia Annechini, Gianluca Gaidano, Michele Spina, Roberto Sartori, Claudia Castellino, Benedetta Puccini, Annalisa Arcari, Sara Bigliardi, Giorgia Matta, Michele Merli, Donato Mannina, Dario Marino, Piero Galieni, Fabrizio Ciambelli, Gerardo Musuraca, Chiara Bottelli, Cristina Muzi, Simone Ferrero, Stefano Luminari, Marco Ladetto, Giovannino Ciccone, Umberto Vitolo
Journal: Blood
Blood (2023) 142 (Supplement 1): 982.
https://doi.org/10.1182/blood-2023-174901
Published: 2023
Journal Articles

MRD Monitoring By Euroclonality IGH Based NGS Approach Predicts Outcome in Follicular Lymphoma Patients Lacking a Conventional BCL2::IGH Marker: A Substudy from the Fondazione Italiana Linfomi (FIL) FOLL12 Trial

Elisa Genuardi, Beatrice Alessandria, Irene Della Starza, Francesca Guerrini, Riccardo Bomben, Daniela Drandi, Martina Ferrante, Clara Bono, Roberta Soscia, Tamara Bittolo, Simone Ragaini, Salvatrice Mancuso, Emanuele Cencini, Nicola Di Renzo, Clara Mannarella, Marco Murineddu, Vittorio Stefoni, Riccardo Centurioni, Luca Baldini, Aurora Maria Civita, Valter Gattei, Sara Galimberti, Ilaria Del Giudice, Benedetto Bruno, Massimo Federico, Marco Ladetto, Christiane Pott, Stefano Luminari, Simone Ferrero
Journal: Blood
Blood (2023) 142 (Supplement 1): 4373.
https://doi.org/10.1182/blood-2023-181813
Published: 2023
Journal Articles

Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Older Patients with Mantle Cell Lymphoma: A Phase 2 Study By the Fondazione Italiana Linfomi (FIL)

Carlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, Andrea Evangelista, Isacco Ferrarini, Maria Chiara Tisi, Anna Merli, Stefano Fiori, Vittorio Ruggero Zilioli, Alessandro Re, Claudia Castellino, Francesco Piazza, Paolo Corradini, Stefan Hohaus, Gerardo Musuraca, Francesca Gaia Rossi, Benedetta Puccini, Federica Cavallo, Filippo Ballerini, Roberta Sciarra, Alice Di Rocco, Annalisa Arcari, Carola Boccomini, Francesco Merli, Guido Gini, Monica Tani, Riccardo Bruna, Vincenzo Pavone, Andrés José María Ferreri, Armando Santoro, Caterina Patti, Giacomo Loseto, Marco Ladetto, Michele Merli, Michele Spina, Pier Luigi Zinzani, Piero Maria Stefani, Sara Usai, Stefano Pileri, Monica Balzarotti
Journal: Blood
Blood (2023) 142 (Supplement 1): 737.
https://doi.org/10.1182/blood-2023-179169
Published: 2023
Journal Articles

Early-Stage Follicular Lymphoma: Learnings from the Final Analysis of the Multicenter Phase II FIL (Fondazione Italiana Linfomi) “Miro” Trial, Combining Local Radiotherapy and MRD-Driven Immunotherapy

Alessandro Pulsoni, Maria Elena Tosti, Simone Ferrero, Stefano Luminari, Alessandra Dondi, Anna Marina Liberati, Natalia Cenfra, Daniela Renzi, Manuela Zanni, Carola Boccomini, Andrés José María Ferreri, Sara Rattotti, Vittorio Ruggero Zilioli, Patrizia Bernuzzi, Silvia Bolis, Gerardo Musuraca, Luca Nassi, Tommasina Perrone, Caterina Stelitano, Antonella Anastasia, Paolo Corradini, Giovanni Partesotti, Francesca Re, Emanuele Cencini, Clara Mannarella, Donato Mannina, Anna Lia Molinari, Monica Tani, Giorgia Annechini, Giovanni Manfredi Assanto, Lavinia Grapulin, Anna Guarini, Marzia Cavalli, Lucia Anna De Novi, Riccardo Bomben, Elena Ciabatti, Barbara Mantoan, Daniela Drandi, Irene Della Starza, Luca Arcaini, Umberto Ricardi, Valter Gattei, Sara Galimberti, Marco Ladetto, Robin Foà, Ilaria Del Giudice
Journal: Blood
Blood (2023) 142 (Supplement 1): 4399.
https://doi.org/10.1182/blood-2023-182946
Published: 2023
Journal Articles

Outcome of Allogeneic Stem Cell Transplantation in FLT3-TKD-Mutated AML - a Study on Behalf of the Acute Leukemia Working Party of the EBMT

Thomas Heinicke, Myriam Labopin, Didier Blaise, Jaime Sanz, Ibrahim Yakoub-Agha, Thomas Cluzeau, Marco Ladetto, Jürgen Finke, Eric Deconinck, Jurjen Versluis, Urpu Salmenniemi, Andreas Neubauer, Eolia Brissot, Ali Bazarbachi, Arnon Nagler, Jordi Esteve, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 4976.
https://doi.org/10.1182/blood-2023-174233
Published: 2023
Journal Articles

Impact of COVID-19 Pandemic Waves on Outcomes of Patients with Previously Untreated Advanced Follicular Lymphoma Enrolled in the Urban Ambispective Study in Italy

Antonio Pinto, Emanuele Guardalben, Marica Battista, Giulia Chiara Gazzoli, Michele Merli, Annalisa Chiarenza, Tommasina Perrone, Attilio Guarini, Nicola Di Renzo, Carlo Visco, Agostino Tafuri, Roberta Murru, Felicetto Ferrara, Jacopo Olivieri, Attilio Olivieri, Andrés J M Ferreri, Marco Ladetto, Pier Luigi Zinzani, Luca Arcaini, Giuseppe Gritti
Journal: Blood
Blood (2022) 140 (Supplement 1): 6504–6506.
https://doi.org/10.1182/blood-2022-166486
Published: 2022
Journal Articles

Dissecting MRD Kinetics By Automated Computational Analysis to Improve Outcome Prediction in Mantle Cell Lymphoma: A Bioinformatic Substudy from the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial

Francesca Cordero, Simone Ferrero, Simone Pernice, Elisa Genuardi, Roberta Sirovich, Beatrice Alessandria, Andrea Evangelista, Simone Ragaini, Maurizio Martelli, Alice Di Rocco, Alessandro Re, Chiara Pagani, Vittorio Stefoni, Federica Cavallo, Carola Boccomini, Monica Balzarotti, Vittorio Ruggero Zilioli, Maria Gomes da Silva, Luca Arcaini, Melania Celli, Gian Maria Zaccaria, Dora Tortarolo, Sergio Cortelazzo, Marco Ladetto
Journal: Blood
Blood (2022) 140 (Supplement 1): 9375–9377.
https://doi.org/10.1182/blood-2022-159949
Published: 2022
Journal Articles

Efficacy and Safety of Ibrutinib Combined with Standard First-Line Treatment or As Substitute for Autologous Stem Cell Transplantation in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network

Martin Dreyling, Jeanette K. Doorduijn, Eva Gine, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trneny, Vibeke K.J. Vergote, Melania Celli, Ofer Shpilberg, Maria Gomes da Silva, Sirpa Leppa, Linmiao Jiang, Christiane Pott, Wolfram Klapper, Döndü Gözel, Christian Schmidt, Michael Unterhalt, Marco Ladetto, Eva Hoster
Journal: Blood
Blood (2022) 140 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2022-163018
Published: 2022
Journal Articles

Six-Month Doxycycline Is Safe and Effective As Upfront Monotherapy for Stage-I Malt Lymphoma of the Ocular Adnexae: Primary Endpoint Results of the IELSG39 Trial

Andrés J.M. Ferreri, Marianna C. Sassone, Maria Giulia Cangi, Gilda Magliacane, Stefania Zanussi, Elena Flospergher, Fabrizio Marino, Lucia Bongiovanni, Marco Ladetto, Federica Cavallo, Franco Aversa, Antonella Anastasia, Donato Mannina, Anna Pascarella, Daniele Vallisa, Alessandro Pulsoni, Luisella Bonomini, Francesco Bertoni, Riccardo Dolcetti, Emanuele Zucca, Maurilio Ponzoni
Journal: Blood
Blood (2022) 140 (Supplement 1): 6482–6484.
https://doi.org/10.1182/blood-2022-168712
Published: 2022